https://www.forex-news.com/
Forex-News has been the world leading economy news website since 2005. It has been a joyful path full of changing variables in this changing world. During the last three years we have also covered some of the most important news regarding Bitcoin and other cryptocurrencies. Wherever the news are, we are there.
, FDA approves remdesivir to treat hospitalized COVID-19 patients, Forex-News, Forex-News
Bitcoin
$19,232.27
+391.62
Ethereum
$597.86
+4.55
Litecoin
$89.33
+2.58
DigitalCash
$106.49
+1.16
Monero
$128.53
-1.23
Nxt
$0.01
-0
Ethereum Classic
$6.29
+0.04
Dogecoin
$0.00
-0

FDA approves remdesivir to treat hospitalized COVID-19 patients

7
, FDA approves remdesivir to treat hospitalized COVID-19 patients, Forex-News, Forex-News



, FDA approves remdesivir to treat hospitalized COVID-19 patients, Forex-News, Forex-News

Oct. 22 (UPI) — The U.S. Food and Drug Administration on Thursday approved remdesivir as a treatment for COVID-19, drugmaker Gilead Sciences announced.

Gilead, which sells remdesivir under the brand name Veklury, issued a statement saying it was the first drug to be approved to treat COVID-19 patients that require hospitalization after previously being authorized by the FDA for emergency use.

“As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19,” the company said.

Veklury was approved for treatment of adults and pediatric patients aged 12 or older and weighing at least 88 pounds and “should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care,” Gilead said.

The company added that the approval was based on three randomized controlled trials including final results of a double-blind, placebo-controlled trial by the National Institute of Allergy and Infectious Diseases which showed treatment with Velkury resulted in “clinically meaningful improvements across multiple outcome assessments” compared with patients who received the placebo.

President Donald Trump was given multiple doses of remdesivir after he was hospitalized with COVID-19 earlier this month.

A study by the World Health Organization last week found that remdesivir along with hydroxychloroquine, lopinavir and interferon regimens “appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay.”

Sign up for our daily Top News Newsletter

.



, FDA approves remdesivir to treat hospitalized COVID-19 patients, Forex-News, Forex-News

Get real time updates directly on you device, subscribe now.

, FDA approves remdesivir to treat hospitalized COVID-19 patients, Forex-News, Forex-News

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More